LogicBio Therapeutics Provides Business Updates
/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2...
Source: prnewswire.com
Stay updated with breaking news from New Generide Development Candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2...
LEXINGTON, Mass., Dec. 22, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. , a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial... | December 22, 2021
LogicBio Therapeutics Provides Business Updates - read this article along with other careers information, tips and advice on BioSpace